Industry Background:
Human Blood Warmer market is expected to mark significant growth over forecasted period owing to increasing incidence of hyperthermia in infant population, growing incidences of thyroid conditions and diabetes and technological advancement. There has been significant rise in number of people affected through hyperthermia with figure stood up to 1301 annual deaths in United States alone in 2018, the future for Human Blood Warmer promising. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on fastest-growing verticals in the cure of diseases.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
High Growth Market | Asia Pacific |
Unit | Value (USD Million) |
Key Companies Profiled | Smiths Medical (United States), Stryker (United States), 3M (United States), Vital Signs (BD) (United States), The 37Company (United States), Gambro (Baxter international) (United States), Thermal Angel, Barkey (United States), Belmont (France), Stihler Electronic (Germany) and Biegler (Austria) |
According to AMA, the market for Human Blood Warmer is expected to register a CAGR of 7.6% during the forecast period to 2030. This growth is primarily driven by Increase Burden of Hypothermia Cases Boost the Human Blood Warmer Market. and Incidence of Hyperthermia in Cold Industries Fuelled Up the Human Blood Warmer Market..
Globally, a noticeable market trend is evident Increased demand in Asia-pacific regions The Health Care sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Smiths Medical (United States), Stryker (United States), 3M (United States), Vital Signs (BD) (United States), The 37Company (United States), Gambro (Baxter international) (United States), Thermal Angel, Barkey (United States), Belmont (France), Stihler Electronic (Germany) and Biegler (Austria), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. In Human Blood Warmer market, it has been observed that most of the companies are upgrading or introducing different temperature management treatment and Blood and fluid warmer systems that provide more enable patient treatment by maintaining normal body temperature to avoid hypothermia.
Key Developments in the Market:
In May 2022, Quantum Blood and Fluid Warming System from LifeWarmer was introduced. The product is a revolutionary innovation that has succeeded in closing a critical ability divide previously left exposed by other commercial off-the-shelf fluid warmers currently fielded. Size, weight, performance, and ease of use are no longer handicaps to the delivery of whole blood in far forward and near point of injury (POI) prehospital casualty management.
In April 2021, Danish MedTech company MEQU launched an in-hospital solution, °M Station, for its blood and IV fluid warming device, °M Warmer System. This product is designed to be used in emergency rooms, operating theatres, intensive care units.
Regulatory Insights:
“According to National Centre for Biotechnology Information, its consolidate safety and preservation of blood require refrigerated storage and delivery up to the moment of transfusion .Modern methods of very rapid transfusion in resuscitation would cause clinically dangerous hypothermia if unmodified, ice-cold blood were to be so transfused.”
Influencing Trend:
Increased demand in Asia-pacific regions
Market Growth Drivers:
Increase Burden of Hypothermia Cases Boost the Human Blood Warmer Market. and Incidence of Hyperthermia in Cold Industries Fuelled Up the Human Blood Warmer Market.
Challenges:
Limitation on the Speed Level of Graphic Processors are Anticipated to Challenge the Market. and High Research and Development Expenses Hampers the Global Market.
Restraints:
Consumption of Abusive Drugs Can Increase the Risk of Hyperthermia Hampers the Human Blood Warmer Market. and Low Awareness among the Customers.
Opportunities:
Incidence of Infant Population and Geriatic Leads to Grow the Human Blood Warmer Market. and Upsurge Demand of Surgical Procedures Boost the Market.
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Human Blood Warmer Market
- Analysis about New Entrants in Human Blood Warmer Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators
Against this Challenging Backdrop, Human Blood Warmer Study Sheds Light on
The Human Blood Warmer Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Human Blood Warmer industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Human Blood Warmer industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.